CN102827080B - 一种伊伐布雷定的合成方法及其中间产物 - Google Patents
一种伊伐布雷定的合成方法及其中间产物 Download PDFInfo
- Publication number
- CN102827080B CN102827080B CN201210334804.6A CN201210334804A CN102827080B CN 102827080 B CN102827080 B CN 102827080B CN 201210334804 A CN201210334804 A CN 201210334804A CN 102827080 B CN102827080 B CN 102827080B
- Authority
- CN
- China
- Prior art keywords
- compound
- synthetic method
- ivabradine
- methyl
- propylamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- ACRHBAYQBXXRTO-OAQYLSRUSA-N ivabradine Chemical compound C1CC2=CC(OC)=C(OC)C=C2CC(=O)N1CCCN(C)C[C@H]1CC2=C1C=C(OC)C(OC)=C2 ACRHBAYQBXXRTO-OAQYLSRUSA-N 0.000 title claims abstract description 34
- 238000010189 synthetic method Methods 0.000 title claims abstract description 17
- 229960003825 ivabradine Drugs 0.000 title abstract description 10
- 239000013067 intermediate product Substances 0.000 title abstract description 4
- 150000001875 compounds Chemical class 0.000 claims abstract description 14
- 230000002829 reductive effect Effects 0.000 claims abstract description 5
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 26
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 claims description 20
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 17
- 239000002904 solvent Substances 0.000 claims description 17
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 15
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 claims description 9
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 claims description 8
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 8
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 claims description 7
- 229910052801 chlorine Inorganic materials 0.000 claims description 7
- 239000000460 chlorine Substances 0.000 claims description 7
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- 125000001475 halogen functional group Chemical group 0.000 claims description 6
- 238000006467 substitution reaction Methods 0.000 claims description 6
- 229940059260 amidate Drugs 0.000 claims description 4
- 229910052794 bromium Inorganic materials 0.000 claims description 4
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 4
- NPUKDXXFDDZOKR-LLVKDONJSA-N etomidate Chemical compound CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1 NPUKDXXFDDZOKR-LLVKDONJSA-N 0.000 claims description 4
- 229910052731 fluorine Inorganic materials 0.000 claims description 4
- 229910052740 iodine Inorganic materials 0.000 claims description 4
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 229910052987 metal hydride Inorganic materials 0.000 claims description 4
- 150000004681 metal hydrides Chemical class 0.000 claims description 4
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000012280 lithium aluminium hydride Substances 0.000 claims description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical group [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- 150000001263 acyl chlorides Chemical class 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 238000006555 catalytic reaction Methods 0.000 claims description 2
- 125000001033 ether group Chemical group 0.000 claims description 2
- 239000011737 fluorine Substances 0.000 claims description 2
- 125000001153 fluoro group Chemical group F* 0.000 claims description 2
- 239000011630 iodine Substances 0.000 claims description 2
- 125000002346 iodo group Chemical group I* 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 239000012279 sodium borohydride Substances 0.000 claims description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 12
- 238000002360 preparation method Methods 0.000 abstract description 7
- UMIVXZPTRXBADB-UHFFFAOYSA-N benzocyclobutene Chemical class C1=CC=C2CCC2=C1 UMIVXZPTRXBADB-UHFFFAOYSA-N 0.000 abstract description 4
- 230000002194 synthesizing effect Effects 0.000 abstract 3
- 238000006243 chemical reaction Methods 0.000 description 18
- 238000003756 stirring Methods 0.000 description 13
- 239000000243 solution Substances 0.000 description 8
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- -1 N-methyl-3-chloro propyl amine hydrochloric acid salt Chemical class 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical group OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 1
- JFBZPFYRPYOZCQ-UHFFFAOYSA-N [Li].[Al] Chemical compound [Li].[Al] JFBZPFYRPYOZCQ-UHFFFAOYSA-N 0.000 description 1
- WXIUBYCJAAEOFL-UHFFFAOYSA-N [S].ClOCl Chemical class [S].ClOCl WXIUBYCJAAEOFL-UHFFFAOYSA-N 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000002327 cardiovascular agent Substances 0.000 description 1
- 229940125692 cardiovascular agent Drugs 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000003810 ethyl acetate extraction Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical class [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 1
- 235000007715 potassium iodide Nutrition 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210334804.6A CN102827080B (zh) | 2012-09-12 | 2012-09-12 | 一种伊伐布雷定的合成方法及其中间产物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210334804.6A CN102827080B (zh) | 2012-09-12 | 2012-09-12 | 一种伊伐布雷定的合成方法及其中间产物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102827080A CN102827080A (zh) | 2012-12-19 |
CN102827080B true CN102827080B (zh) | 2014-03-19 |
Family
ID=47330421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210334804.6A Active CN102827080B (zh) | 2012-09-12 | 2012-09-12 | 一种伊伐布雷定的合成方法及其中间产物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102827080B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104557573B (zh) * | 2013-10-24 | 2018-02-27 | 上海天慈生物谷生物工程有限公司 | (1s)‑4,5‑二甲氧基‑1‑[(甲基氨基)甲基]苯并环丁烷盐酸盐的制备方法 |
CN105669554A (zh) * | 2016-02-22 | 2016-06-15 | 徐建立 | 一种盐酸伊伐布雷定杂质及其制备方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101284813A (zh) * | 2007-04-12 | 2008-10-15 | 上海优拓医药科技有限公司 | 伊伐布雷定的制备方法 |
CN101434552A (zh) * | 2007-11-16 | 2009-05-20 | 江苏恒瑞医药股份有限公司 | 4,5-二甲氧基-1-(甲基氨基甲基)-苯并环丁烷的拆分 |
CN101768116A (zh) * | 2008-12-29 | 2010-07-07 | 北京德众万全药物技术开发有限公司 | 一种伊伐布雷定的制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2381771T3 (es) * | 2006-11-30 | 2012-05-31 | Cadila Healthcare Limited | Procedimiento para la preparación de hidrocloruro de ivabradina |
-
2012
- 2012-09-12 CN CN201210334804.6A patent/CN102827080B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101284813A (zh) * | 2007-04-12 | 2008-10-15 | 上海优拓医药科技有限公司 | 伊伐布雷定的制备方法 |
CN101434552A (zh) * | 2007-11-16 | 2009-05-20 | 江苏恒瑞医药股份有限公司 | 4,5-二甲氧基-1-(甲基氨基甲基)-苯并环丁烷的拆分 |
CN101768116A (zh) * | 2008-12-29 | 2010-07-07 | 北京德众万全药物技术开发有限公司 | 一种伊伐布雷定的制备方法 |
Non-Patent Citations (2)
Title |
---|
"伊伐布雷定的合成工艺改进";叶晓娟,等;《中国药物化学杂志》;20100430;第20卷(第2期);第106-109页 * |
叶晓娟,等."伊伐布雷定的合成工艺改进".《中国药物化学杂志》.2010,第20卷(第2期),第106-109页. |
Also Published As
Publication number | Publication date |
---|---|
CN102827080A (zh) | 2012-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106279074B (zh) | 一种化合物及其制备方法和在合成布瓦西坦中的用途 | |
CN104177388B (zh) | 一种桥联双酰胺基稀土胺化物及其制备方法和应用 | |
CN106866528A (zh) | 一种制备4‑氨基喹啉衍生物的方法 | |
CN106000465B (zh) | 一种醛与二级酰胺的氧化偶联反应的方法 | |
CN102827080B (zh) | 一种伊伐布雷定的合成方法及其中间产物 | |
CN102391306A (zh) | 螺环苄胺-膦和制备方法及其应用 | |
CN102558069B (zh) | 一种盐酸苯达莫司汀制备过程中的中间体的制备方法 | |
CN102775366A (zh) | 3-(5-甲氧基-1,5-二氧代戊基)-(4s)-苯基噁唑烷-2-酮的制备方法 | |
CN102936223A (zh) | 5-碘-2-甲基苯并咪唑的合成方法及纯化方法 | |
CN106631823A (zh) | 一种氯卡色林中间体的制备方法 | |
CN102827019B (zh) | 一组新的苯并环丁烷化合物及其在化学合成中的应用 | |
CN105585511B (zh) | (r)‑n‑叔丁氧羰基联苯丙氨醇的制备方法 | |
CN102887934B (zh) | 一种屈螺酮的制备方法 | |
CN107513048B (zh) | 一种氘代沃替西汀氢溴酸盐的合成方法 | |
CN106349125B (zh) | 利用锰盐选择性合成(e)‑乙烯基砜化合物的方法 | |
CN105237483B (zh) | 一种对称型嘧啶基碘鎓盐及其制备方法 | |
CN103183680A (zh) | 阿森那平的制备方法 | |
CN109705014B (zh) | 一种新型手性氧化胺配体及其制备方法 | |
CN106565603B (zh) | 一种5,7-二硝基-8-酰胺基喹啉类化合物的合成方法 | |
CN104557763A (zh) | 一种2-异丙基-4-(甲基氨基甲基)噻唑的合成方法 | |
CN108250008A (zh) | 3,3,3`,3`-四甲基-1,1`-螺二氢茚-6,6`-二醇衍生物手性拆分方法 | |
CN106866558B (zh) | 酰基三氮唑类化合物及其制备方法和应用 | |
CN103073520A (zh) | 一种合成2-苯基苯并噻唑及其衍生物的方法 | |
CN108129277A (zh) | 一种合成2,2’-二萘醚的方法 | |
CN102471294A (zh) | 手性环状β-氨基芳基丁酸衍生物、其制备方法及通过其制备手性β-氨基芳基丁酸衍生物的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 222100 Jiangsu city of Lianyungang Province Economic and Technological Development Zone Industrial Zone Dapu Linpu Road No. 22 Patentee after: JIANGSU YUTIAN PHARMACEUTICAL Co.,Ltd. Address before: 222100 Jiangsu city of Lianyungang Province Economic and Technological Development Zone Industrial Zone Dapu Linpu Road No. 22 Patentee before: JIANGSU YUTIAN PHARMACEUTICAL TECHNOLOGY Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Novel synthetic method of ivabradine and novel intermediate product of ivabradine Effective date of registration: 20190911 Granted publication date: 20140319 Pledgee: Bank of China Limited Lianyungang Economic and Technological Development Zone Branch Pledgor: JIANGSU YUTIAN PHARMACEUTICAL Co.,Ltd. Registration number: Y2019980000145 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20201020 Granted publication date: 20140319 Pledgee: Bank of China Limited Lianyungang Economic and Technological Development Zone Branch Pledgor: JIANGSU YUTIAN PHARMACEUTICAL Co.,Ltd. Registration number: Y2019980000145 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Synthesis of ivabradine and its intermediates Effective date of registration: 20201021 Granted publication date: 20140319 Pledgee: Bank of China Limited Lianyungang Economic and Technological Development Zone Branch Pledgor: JIANGSU YUTIAN PHARMACEUTICAL Co.,Ltd. Registration number: Y2020980007001 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210907 Granted publication date: 20140319 Pledgee: Bank of China Limited Lianyungang Economic and Technological Development Zone Branch Pledgor: JIANGSU YUTIAN PHARMACEUTICAL Co.,Ltd. Registration number: Y2020980007001 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A synthetic method of ivabradine and its intermediate product Effective date of registration: 20211013 Granted publication date: 20140319 Pledgee: Bank of China Limited Lianyungang Economic and Technological Development Zone Branch Pledgor: JIANGSU YUTIAN PHARMACEUTICAL Co.,Ltd. Registration number: Y2021980010606 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20221130 Granted publication date: 20140319 Pledgee: Bank of China Limited Lianyungang Economic and Technological Development Zone Branch Pledgor: JIANGSU YUTIAN PHARMACEUTICAL Co.,Ltd. Registration number: Y2021980010606 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A synthetic method of ivabradine and its intermediate product Effective date of registration: 20221206 Granted publication date: 20140319 Pledgee: Bank of China Limited Lianyungang Economic and Technological Development Zone Branch Pledgor: JIANGSU YUTIAN PHARMACEUTICAL Co.,Ltd. Registration number: Y2022980025301 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |